These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39267841)

  • 21. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
    Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
    Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-gaussian models of 3-Tesla diffusion-weighted MRI for the differentiation of pancreatic ductal adenocarcinomas from neuroendocrine tumors and solid pseudopapillary neoplasms.
    Shi YJ; Li XT; Zhang XY; Zhu HT; Liu YL; Wei YY; Sun YS
    Magn Reson Imaging; 2021 Nov; 83():68-76. PubMed ID: 34314825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-energy computed tomography for predicting histological grading and survival in patients with pancreatic ductal adenocarcinoma.
    Chen W; Lin G; Li X; Feng Y; Mao W; Kong C; Hu Y; Gao Y; Yang W; Chen M; Yan Z; Xia S; Lu C; Xu M; Ji J
    Eur Radiol; 2024 Oct; ():. PubMed ID: 39414655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection.
    Sun HT; Zhang SL; Liu K; Zhou JJ; Wang XX; Shen TT; Song XH; Guo YL; Wang XL
    J Magn Reson Imaging; 2019 Aug; 50(2):397-409. PubMed ID: 30589158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of Non-functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden-Based Prediction Model.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM
    World J Surg; 2021 Jul; 45(7):2134-2141. PubMed ID: 33768309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role and predictors of lymph node involvement in pancreatic neuroendocrine tumors.
    Ren SJ; Tan QQ; Cao D; Ke NW; Liu XB; Wang X
    Eur J Radiol; 2023 May; 162():110772. PubMed ID: 36940547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
    Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
    Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
    Hu X; Shi S; Wang Y; Yuan J; Chen M; Wei L; Deng W; Feng ST; Peng Z; Luo Y
    Radiol Med; 2024 Jan; 129(1):1-13. PubMed ID: 37861978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
    Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
    Han X; Xu X; Ma H; Ji Y; Wang D; Kuang T; Wu W; Song B; Li G; Jin G; Lou W
    Endocr Connect; 2018 Feb; 7(2):355-363. PubMed ID: 29472376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling.
    Starzyńska T; Karczmarski J; Paziewska A; Kulecka M; Kuśnierz K; Żeber-Lubecka N; Ambrożkiewicz F; Mikula M; Kos-Kudła B; Ostrowski J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.